CLRB - Cellectar down 25% on $10M capital raise May, 16 2019 10:37 AM Cellectar Biosciences Inc. Cellectar Biosciences (CLRB -25.4%) obliterates yesterday's 24% spike with its $10M direct stock offering to institutional investors.More news on: Cellectar Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...